Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · IEX Real-Time Price · USD
5.83
+0.03 (0.52%)
May 31, 2024, 4:00 PM EDT - Market closed
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for FHTX stock have an average target of 14.5, with a low estimate of 6.00 and a high estimate of 20. The average target predicts an increase of 148.71% from the current stock price of 5.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FHTX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +243.05% | May 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +243.05% | May 1, 2024 |
Wedbush | Wedbush | Buy Reiterates $13 | Buy | Reiterates | $13 | +122.98% | Apr 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +243.05% | Apr 10, 2024 |
Wedbush | Wedbush | Buy Reiterates $13 | Buy | Reiterates | $13 | +122.98% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
28.96M
from 34.16M
Decreased by -15.21%
Revenue Next Year
31.46M
from 28.96M
Increased by 8.63%
EPS This Year
-2.21
from -2.34
EPS Next Year
-1.72
from -2.21
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 36.9M | 56.7M | 67.2M | 345.3M | 610.9M |
Avg | 29.0M | 31.5M | 38.6M | 170.4M | 311.2M |
Low | 21.3M | n/a | n/a | 76.3M | 158.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.9% | 95.8% | 113.6% | 794.2% | 258.6% |
Avg | -15.2% | 8.6% | 22.8% | 341.2% | 82.7% |
Low | -37.5% | - | - | 97.7% | -6.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -2.07 | -1.14 | -0.95 | -0.78 | 0.42 |
Avg | -2.21 | -1.72 | -1.73 | -1.30 | -0.10 |
Low | -2.51 | -2.31 | -2.23 | -1.80 | -0.43 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.